FDA
approval
· 2017-04-12
FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)
Summary
FDA approved a supplemental application for Imodium Multi-Symptom Relief, a combination of loperamide hydrochloride and dimethicone from Kenvue Brands LLC. The …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE)